Promore Pharma Reaches the Clean File Milestone in its Phase II Clinical Trial with Ensereptide

STOCKHOLM, SWEDEN / ACCESSWIRE / February 27, 2023 / Promore Pharma (STO:PROMO) (FRA:8T0) STOCKHOLM, 27 February, 2023 - Promore Pharma AB announces today that the Clean File milestone has been achieved in the PHSU05 clinical trial. The publication …